Forty Seven, Inc. (FTSV)

Trade FTSV now with
12/11/2019 11:38:09 PM Forty Seven Prices Public Offering Of 4.86 Mln Shares At $35/Shr
9/3/2019 8:14:00 AM Forty Seven Granted Fast Track Designation For Magrolimab For Myelodysplastic Syndrome And Acute Myeloid Leukemia
8/13/2019 4:04:31 PM Forty Seven Q2 Loss/share $0.74 Vs. Loss $2.52 Year Ago
7/17/2019 9:00:17 PM Forty Seven Prices Underwritten Public Offering Of 9.38 Mln Shares At $8.00/shr
7/11/2019 7:14:55 AM Forty Seven And Ono Pharma Sign Regional License Agreement To Commercialize 5F9 In Select Asian Markets
1/7/2019 8:24:50 AM Forty Seven Outlines Its Strategic Plan And Expected Milestones For 2019
11/13/2018 8:23:06 AM Forty Seven Q3 Net Loss $21.7 Mln Or $0.71/shr Vs Net Loss Of $10.8 Mln Or $1.67/shr Last Year
10/3/2018 8:08:16 AM Forty Seven Announces Formation Of Scientific Advisory Board
8/13/2018 4:06:53 PM Forty Seven Q2 Loss/share $2.52 Vs. Loss $1.68 Year Ago